This website includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of Bruin Biometrics LLC management and are subject to significant risks and uncertainties.
There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of medical device industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Bruin Biometrics LLC ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of Bruin Biometrics LLC patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
Bruin Biometrics LLC undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.
Have questions about our company, products or pipeline? We'd like to hear from you.